<?xml version="1.0" encoding="ISO-8859-1" ?>    <rss version="2.0"><channel><title>NIH Funding Opportunities (Notices, PA, RFA)</title><link>http://grants.nih.gov/grants/guide/WeeklyIndex.cfm</link><description>Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.</description><language>en-us</language><pubDate>Tue, 18 Mar 2014 11:40:46 EST</pubDate>     <item>      <title>Notice of Clarification to Award Budget of PAR-14-051 "Mechanisms of Behavior Change in the Treatment of Alcohol Use Disorders (R01)"</title>       <link>http://grants.nih.gov/grants/guide/notice-files/NOT-AA-14-003.html</link>       <description>Notice NOT-AA-14-003 from the NIH Guide for Grants and Contracts</description>       <pubDate>Tue, 18 Mar 2014 11:35:39 EST</pubDate>      </item>     <item>      <title>Notice of Clarification for Section IV - 5. Funding Restrictions in RFA-OH-14-004 "Miner Safety and Health Training Program - Western United States (U60)"</title>       <link>http://grants.nih.gov/grants/guide/notice-files/NOT-OH-14-005.html</link>       <description>Notice NOT-OH-14-005 from the NIH Guide for Grants and Contracts</description>       <pubDate>Tue, 18 Mar 2014 11:40:45 EST</pubDate>      </item>       <item>      <title>Convener of Discussions on Medical Policy Issues Impacting Drug Development (U13)  </title>       <link>http://grants.nih.gov/grants/guide/rfa-files/RFA-FD-14-003.html</link>       <description><![CDATA[       Funding Opportunity RFA-FD-14-003 from the NIH Guide for Grants and Contracts.       This FOA, issued by the Office of Medical Policy (OMP), Center for Drug Evaluation and Research, Food and Drug Administration, solicits grant applications from neutral, independent institutions and/or organizations that propose methods for convening a broad range of stakeholders, to include those with relevant expertise, and that would support conferences and meetings to explore and address medical policy issues during drug development, review, and surveillance.   In addition, the awardee would be expected to synthesize, summarize, and communicate findings from these conferences and meetings to a broad range of organizations and individuals that have the capability to use the information to further impact the entire lifecycle of drug development, including the premarket and post-market settings.         ]]></description>       <pubDate>Mon, 17 Mar 2014 11:15:29 EST</pubDate>      </item></channel></rss>